603579.SH
荣泰健康
SSE · Consumer Cyclical · Leisure · CN
CNY 17.55
−2.66%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.6B | 1.6B | 1.6B | 1.9B | 2.0B |
| Cost of Revenue | 1.1B | 1.1B | 1.1B | 1.3B | 1.5B |
| Gross Profit | 491.6M | 483.3M | 505.9M | 566.7M | 531.8M |
| Operating Expenses | |||||
| R&D Expense | 97.9M | 93.3M | 80.1M | 80.2M | 88.7M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 88.2M | 87.2M | 86.7M | 78.5M | 70.7M |
| Selling & Marketing Expense | 223.5M | 205.9M | 179.6M | 199.3M | 209.6M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 452.7M | 429.8M | 344.0M | 353.3M | 355.5M |
| Cost and Expenses | 1.6B | 1.5B | 1.4B | 1.6B | 1.8B |
| Operating Income (EBIT) | 198.2M | 183.9M | 210.4M | 236.0M | 186.5M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 199.0M | 184.4M | 210.0M | 230.2M | 179.4M |
| Income Tax Expense | 23.8M | 34.4M | 18.2M | 26.9M | 14.7M |
| Bottom Line | |||||
| Net Income | 176.5M | 150.7M | 191.9M | 202.7M | 164.2M |
| Earnings from Cont. Ops | 175.2M | 150.0M | 191.8M | 203.3M | 164.7M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 176.5M | 150.7M | 191.9M | 202.7M | 164.2M |
| Per Share | |||||
| Basic EPS | CN¥0.95 | CN¥0.83 | CN¥1.11 | CN¥1.17 | CN¥1.23 |
| Diluted EPS | CN¥0.95 | CN¥0.83 | CN¥0.97 | CN¥1.17 | CN¥1.23 |
| Revenue Per Share | CN¥8.13 | CN¥8.66 | CN¥9.23 | CN¥10.71 | CN¥15.02 |
| Shares | |||||
| Basic Shares Outstanding | 199.3M | 181.6M | 172.9M | 173.3M | 133.5M |
| Diluted Shares Outstanding | 199.3M | 181.6M | 172.9M | 173.3M | 133.5M |
| Profitability Metrics | |||||
| EBITDA | — | 245.9M | 270.8M | 305.7M | 259.2M |
| D&A | — | 62.0M | 60.4M | 69.7M | 72.6M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026